Anteilseigner
Frazier Life Sciences Management LP (17,29 %) Medicxi Ventures (Jersey) Ltd. (12,76 %) Invesco Advisers, Inc. (4,92 %) Takeda Pharmaceutical (4,77 %) Deerfield Management Co. LP (4,13 %) BlackRock Fund Advisors (4,12 %) Ensign Peak Advisors, Inc. (3,90 %) NEA Management Co. LLC (3,35 %) The Vanguard Group, Inc. (3,29 %) Avidity Partners Management LP (2,97 %) 683 Capital Management LLC (2,82 %) Jennison Associates LLC (2,82 %) Gilder, Gagnon, Howe & Co. LLC (1,74 %) Propel Bio Management LLC (1,49 %) Decheng Capital LLC (1,45 %) Geode Capital Management LLC (1,28 %) Catalys Pacific LLC (1,23 %)
Kontakt
Phathom Pharmaceuticals Inc.